GRIFFITH DAVID ANDREW,GRIFFITH David Andrew,DOW ROBERT LEE,DOW Robert Lee,SOUTHERS JR. JAMES ALFRED,SOUTHERS JR. James Alfred,EDMONDS DAVID JAMES,EDMONDS David James
申请号：
SI201230417
公开号：
SI2699576T1
申请日:
2012.04.09
申请国别(地区):
SI
年份:
2016
代理人:
摘要：
The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof wherein G is R1, R2 and R3 are as described herein pharmaceutical compositions thereof and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal.
